Unfavourable risk factor control after coronary events in routine clinical practice

[1]  Massimo F. Piepoli,et al.  2016 European Guidelines on cardiovascular disease prevention in clinical practice , 2017, International Journal of Behavioral Medicine.

[2]  Stefan Störk,et al.  EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries , 2016, European journal of preventive cardiology.

[3]  T. Dammen,et al.  The role of medical and psychosocial factors for unfavourable coronary risk factor control , 2016, Scandinavian cardiovascular journal : SCJ.

[4]  A. Maggioni,et al.  Secondary prevention after acute myocardial infarction: Drug adherence, treatment goals, and predictors of health lifestyle habits. The BLITZ-4 Registry , 2015, European journal of preventive cardiology.

[5]  Peter Scarborough,et al.  Cardiovascular disease in Europe--epidemiological update 2015. , 2015, European heart journal.

[6]  H. McGee,et al.  Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology , 2015, European journal of preventive cardiology.

[7]  J. Tardif,et al.  Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registry , 2015, European journal of preventive cardiology.

[8]  J. Lisspers,et al.  Study of Patient Information after percutaneous Coronary Intervention (SPICI): should prevention programmes become more effective? , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[9]  Deepak L. Bhatt,et al.  Non-adherence to cardiovascular medications. , 2014, European heart journal.

[10]  G. Sulo,et al.  Trends in acute myocardial infarction event rates and risk of recurrences after an incident event in Norway 1994 to 2009 (from a Cardiovascular Disease in Norway Project). , 2014, The American journal of cardiology.

[11]  F. Gaita,et al.  Discontinuation of dual antiplatelet therapy over 12 months after acute coronary syndromes increases risk for adverse events in patients treated with percutaneous coronary intervention: systematic review and meta-analysis. , 2014, Journal of interventional cardiology.

[12]  P. Austin,et al.  Socioeconomic Status, Functional Recovery, and Long-Term Mortality among Patients Surviving Acute Myocardial Infarction , 2013, PloS one.

[13]  Peter Scarborough,et al.  Cardiovascular disease in Europe: epidemiological update. , 2014, European heart journal.

[14]  Hassan Khan,et al.  Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. , 2013, European heart journal.

[15]  C. Held,et al.  Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study , 2013, European journal of preventive cardiology.

[16]  S. Maes,et al.  Lifestyle modification programmes for patients with coronary heart disease: a systematic review and meta-analysis of randomized controlled trials , 2013, European journal of preventive cardiology.

[17]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[18]  Deepak L. Bhatt,et al.  Effects of adherence to guidelines for the control of major cardiovascular risk factors on outcomes in the REduction of Atherothrombosis for Continued Health (REACH) Registry Europe , 2011, Heart.

[19]  S. Yusuf,et al.  Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes , 2010, Circulation.

[20]  K. Kotseva,et al.  Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries , 2009, The Lancet.

[21]  L. Tavazzi,et al.  Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. , 2008, Archives of internal medicine.

[22]  Deepak L. Bhatt,et al.  Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry , 2008, European heart journal.

[23]  B. Hustvedt,et al.  Reliability and validity of self-reported physical activity in the Nord-Trøndelag Health Study — HUNT 1 , 2008, Scandinavian journal of public health.

[24]  Martin McKee,et al.  The economic consequences of non-communicable diseases and injuries in the Russian Federation. Copenhagen, WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies. , 2007 .

[25]  P. Ridker,et al.  Impact of Traditional and Novel Risk Factors on the Relationship Between Socioeconomic Status and Incident Cardiovascular Events , 2006, Circulation.

[26]  Deepak L. Bhatt,et al.  International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. , 2006, JAMA.

[27]  L. Erhardt.  Barriers to effective implementation of guideline recommendations. , 2005, The American journal of medicine.

[28]  S. Yusuf,et al.  WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE). , 2005, Bulletin of the World Health Organization.

[29]  S. Ebrahim,et al.  Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups. , 2004, Health technology assessment.

[30]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[31]  J. Otterstad.  Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease , 2003, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[32]  Shah Ebrahim,et al.  JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda , 2016 .

[33]  BOULIN,et al.  Classification and Diagnosis of Diabetes. , 2022, Primary care.